Canada: Permitted as an ingredient in natural health products (NHPs) under Health Canadas NPN licensing system
Our KLOW protocol combines both (along with TB-500 and GHK-Cu) for exactly this reason
A few other states are planning or considering obesity drug restrictions in state fiscal year 2026 or 2027, and state interest in expanding coverage of obesity drugs is also waning according to this years survey, with states continuing to report cost as the key factor contributing to obesity drug coverage decisions
As a board-certified endocrinologist and evidence-based clinician from Johns Hopkins, I cannot ever recommend that people should go and get compounded semaglutide. However, given Hughes medical background and her knowledge that her friend and the wider group had been doing it for about a year with no out-of-the-ordinary side effects she decided it was worth the risk
Journal reference: Shapiro, B
But she says the studies conducted so far to assess the impacts of combining psychiatric medication and GLP-1s are reassuring. Even though the findings from these studies are comforting, it took me years to find the right combination of meds to treat my mental illnesses